Treatment of atypical haemolytic uraemic syndrome in the era of eculizumab
Véronique Frémeaux-Bacchi
Clin Kidney J (2012) 5: 4–6. doi: 10.1093/ckj/sfr177
The author would like to apologise for the omission of the word ‘haemolytic’ in the original submission. The title of the published Editorial Comment should have read ‘Treatment of atypical haemolytic uraemic syndrome in the era of eculizumab’.
